Uniphar (LON:UPR) Trading Down 1.1% – Time to Sell?

Uniphar plc (LON:UPR) shares traded down 1.1% on Wednesday . The stock traded as low as GBX 178 ($2.27) and last traded at GBX 179 ($2.28). 6,308 shares changed hands during trading, a decline of 82% from the average session volume of 35,697 shares. The stock had previously closed at GBX 181 ($2.31).

Analysts Set New Price Targets

Separately, Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a GBX 310 ($3.95) price objective on shares of Uniphar in a research note on Wednesday, September 4th.

Uniphar Price Performance

The company has a debt-to-equity ratio of 119.43, a current ratio of 0.90 and a quick ratio of 0.60. The stock has a fifty day simple moving average of GBX 191.85 and a 200-day simple moving average of GBX 208.56. The company has a market capitalization of £488.71 million, a price-to-earnings ratio of 1,278.57 and a beta of 0.75.

Uniphar Company Profile

Uniphar plc operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, The Netherlands, and internationally. The company operates through three divisions: Medtech, Pharma, and Supply Chain & Retail. The Medtech division offers outsourced sales; and marketing, distribution, and support services to medical device manufacturers.